◆英語タイトル:Beth Israel Deaconess Medical Center Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011920
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月13日
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Beth Israel Deaconess Medical Center Inc (BIDMC), a subsidiary of CareGroup Inc is a healthcare center that offers clinical care, biomedical research and education, health and wellness services. The center offers patient and family care services such as admitting, case management, ethics support, nursing, nutritional services and volunteer services, among others. It offers biomedical research programs which include vascular and transplantation research, signal transduction and molecular imaging services. The center offers treatment in therapeutic areas of cardiology, obstetrics, gastrointestinal disorders and cancer care. It operates healthcare centers in Milton, Needham, Plymouth, Chelsea and Lexington. BIDMC is headquartered in Boston, Massachusetts, the US.
Beth Israel Deaconess Medical Center Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Beth Israel Deaconess Medical Center Inc, Medical Devices Deals, 2011 to YTD 2017 9
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Mustang Bio Enters into Agreement with Beth Israel Deaconess 11
Genus Oncology Partners with Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center 12
CureMeta Enters into Research Agreement with Beth Israel Deaconess Medical Center 13
Jackson Lab Enters into Co-Development Agreement with Beth Israel Deaconess Medical Center 14
Licensing Agreements 15
Acceleron Pharma Enters into Licensing Agreement with Beth Israel Deaconess Medical Center 15
Acquisition 16
Beth Israel Deaconess Medical Center Finalizes Acquisition Of Jordan Health Systems 16
Beth Israel Deaconess Medical Center Inc – Key Competitors 17
Beth Israel Deaconess Medical Center Inc – Key Employees 18
Beth Israel Deaconess Medical Center Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 20
Recent Developments 21
Government and Public Interest 21
Dec 04, 2017: Study Finds More Than 1 in 6 Patients With Peripheral Arterial Disease Who Undergo Revascularization Readmitted Within 30 Days 21
Dec 16, 2016: Research Team Led by BIDMC’s Robert Gerszten, MD, Receives $11 Million NIH Grant to Study Molecular Changes Linked to Exercise and Physical Activity 23
Apr 18, 2016: Newly Discovered Vulnerability in Breast Tumor Cells Points to Novel Treatment Approach Against Cancer 24
Apr 13, 2016: Researchers Uncover Earliest Events Following HIV Infection, Before Virus Is Detectable 25
Mar 31, 2016: New study implicates unusual class of circular RNAs in cancer 26
Mar 28, 2016: BIDMC Researchers Discover Early Indicators of Pancreatic Cancer 28
Mar 16, 2016: Mitochondrial Metabolism Linked to Acute Kidney Injury 29
Feb 15, 2016: Genetic variation shown in patients with severe vascular complications of infection 31
Jan 28, 2016: New Insights into PI3K Pathway and Cancer Metabolism 32
Product News 34
Nov 09, 2016: New Therapeutic Vaccine Approach Holds Promise for HIV Remission 34
Jul 27, 2016: New Proteomics Tool Reveals Novel Biomarkers for Cardiovascular Risk 36
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List of Tables
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Key Facts 2
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Beth Israel Deaconess Medical Center Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Beth Israel Deaconess Medical Center Inc, Medical Devices Deals, 2011 to YTD 2017 9
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Mustang Bio Enters into Agreement with Beth Israel Deaconess 11
Genus Oncology Partners with Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center 12
CureMeta Enters into Research Agreement with Beth Israel Deaconess Medical Center 13
Jackson Lab Enters into Co-Development Agreement with Beth Israel Deaconess Medical Center 14
Acceleron Pharma Enters into Licensing Agreement with Beth Israel Deaconess Medical Center 15
Beth Israel Deaconess Medical Center Finalizes Acquisition Of Jordan Health Systems 16
Beth Israel Deaconess Medical Center Inc, Key Competitors 17
Beth Israel Deaconess Medical Center Inc, Key Employees 18
Beth Israel Deaconess Medical Center Inc, Subsidiaries 20
Beth Israel Deaconess Medical Center Inc, Joint Venture 20